{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:22Z","timestamp":1786984462626,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.antiviral.2023.105657","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T17:40:12Z","timestamp":1687714812000},"page":"105657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza"],"prefix":"10.1016","volume":"216","author":[{"given":"Shengrui","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2023.105657_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2023.105657_bib2","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00003495-199958050-00007","volume":"58","author":"Bardsley-Elliot","year":"1999","journal-title":"Oseltamivir. Drugs"},{"key":"10.1016\/j.antiviral.2023.105657_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v10110610","article-title":"Combination therapy with oseltamivir and favipiravir delays mortality but does not prevent oseltamivir resistance in immunodeficient mice infected with pandemic A(H1N1) influenza virus","volume":"10","author":"Baz","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2023.105657_bib5","series-title":"The R251K Substitution in Viral Protein PB2 Increases Viral Replication and Pathogenicity of Eurasian Avian-like H1N1 Swine Influenza Viruses","author":"Cai","year":"2020"},{"key":"10.1016\/j.antiviral.2023.105657_bib7","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2023.105657_bib6","series-title":"Chinese Influenza Weekly Report","year":"2018"},{"key":"10.1016\/j.antiviral.2023.105657_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036113","article-title":"Functional analysis of conserved motifs in influenza virus PB1 protein","volume":"7","author":"Chu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2023.105657_bib38","author":"Danecek"},{"key":"10.1016\/j.antiviral.2023.105657_bib9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2023.105657_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2023.105657_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proceedings of the Japan Academy, Series B"},{"key":"10.1016\/j.antiviral.2023.105657_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2023.105657_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2023.105657_bib14","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2023.105657_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008937","article-title":"Favipiravir-resistant influenza A virus shows potential for transmission","volume":"17","author":"Goldhill","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2023.105657_bib16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/v2081510","article-title":"Combination chemotherapy for influenza","volume":"2","author":"Govorkova","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2023.105657_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"Hayden","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2023.105657_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2023.105657_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.735305","article-title":"Analysis of the genetic diversity associated with the drug resistance and pathogenicity of influenza A virus isolated in Bangladesh from 2002 to 2019","volume":"12","author":"Hossain","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2023.105657_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2023.105657_bib21","series-title":"Bam-readcount -- Rapid Generation of Basepair-Resolution Sequence Metrics","author":"Khanna","year":"2021"},{"key":"10.1016\/j.antiviral.2023.105657_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/infdis\/jix606","article-title":"Combination therapy with neuraminidase and polymerase inhibitors in nude mice infected with influenza virus","volume":"217","author":"Kiso","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2023.105657_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41598-017-18791-z","article-title":"Sweep Dynamics (SD) plots: computational identification of selective sweeps to monitor the adaptation of influenza A viruses","volume":"8","author":"Klingen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2023.105657_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrmicro3003","article-title":"The role of mutational robustness in RNA virus evolution","volume":"11","author":"Lauring","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2023.105657_bib25","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.antiviral.2023.105657_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep26742","article-title":"Combinations of oseltamivir and T-705 extend the treatment window for highly pathogenic influenza A(H5N1) virus infection in mice","volume":"6","author":"Marathe","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2023.105657_bib27","series-title":"Quasispecies Dynamics of RNA Viruses, Viruses: Essential Agents of Life","first-page":"21","author":"Mart\u00ednez","year":"2012"},{"key":"10.1016\/j.antiviral.2023.105657_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jmv.23990","article-title":"Genetic analysis of post-pandemic 2010-2011 influenza A(H1N1)pdm09 hemagglutinin virus variants that caused mild, severe, and fatal infections in Northern Greece","volume":"87","author":"Melidou","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2014.11.026","article-title":"Within-host nucleotide diversity of virus populations: insights from next-generation sequencing","volume":"30","author":"Nelson","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2023.105657_bib30","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the mutation rates of human influenza A and B viruses","volume":"80","author":"Nobusawa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib31","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/gbe\/evx138","article-title":"The combined effect of oseltamivir and favipiravir on influenza A virus evolution","volume":"9","author":"Ormond","year":"2017","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.antiviral.2023.105657_bib32","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/JVI.03483-14","article-title":"Effective lethal mutagenesis of influenza virus by three nucleoside analogs","volume":"89","author":"Pauly","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26437","article-title":"A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses","volume":"6","author":"Pauly","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2023.105657_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00453","article-title":"Amino acid substitutions HA A150V, PA A343T, and PB2 E627K increase the virulence of H5N6 influenza virus in mice","volume":"9","author":"Peng","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2023.105657_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2023.105657_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.meegid.2016.01.022","article-title":"Adaptation of influenza A(H1N1)pdm09 virus in experimental mouse models","volume":"39","author":"Prokopyeva","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2023.105657_bib37","author":"Robert"},{"key":"10.1016\/j.antiviral.2023.105657_bib39","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.00649-13","article-title":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase","volume":"57","author":"Sangawa","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2023.105657_bib50","doi-asserted-by":"crossref","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.antiviral.2023.105657_bib40","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2023.105657_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.00933-09","article-title":"Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice","volume":"54","author":"Smee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2023.105657_bib42","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1038\/ncomms6509","article-title":"The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication","volume":"5","author":"Song","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2023.105657_bib43","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41564-021-00976-y","article-title":"Ancestral sequence reconstruction pinpoints adaptations that enable avian influenza virus transmission in pigs","volume":"6","author":"Su","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.antiviral.2023.105657_bib44","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1093\/molbev\/msab120","article-title":"MEGA11: molecular evolutionary genetics analysis version 11","volume":"38","author":"Tamura","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.antiviral.2023.105657_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2023.105657_bib46","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/jvi.67.9.5585-5594.1993","article-title":"Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block","volume":"67","author":"Wang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib47","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/infdis\/jiz656","article-title":"Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection","volume":"221","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2023.105657_bib48","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1128\/JVI.75.11.5410-5415.2001","article-title":"Sequences in influenza A virus PB2 protein that determine productive infection for an avian influenza virus in mouse and human cell lines","volume":"75","author":"Yao","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2023.105657_bib49","first-page":"41","article-title":"Evaluation of A Single-reaction method for whole genome sequencing of influenza A virus using next generation sequencing","volume":"29","author":"Zou","year":"2016","journal-title":"Biomed. Environ. Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354223001353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354223001353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:39:03Z","timestamp":1759063143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354223001353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"alternative-id":["S0166354223001353"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2023.105657","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2023.105657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105657"}}